Risks of Nonkeratinocyte Skin Cancers Higher in Solid Organ Transplant Recipients
A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.
Melanoma
Primary Care-Based Screening Ups Thin Melanoma Detection
The incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
Global Burden of Melanoma Considerable, Set to Rise by 2040
The burden from melanoma is estimated to increase to 510,000 new cases and 96,000 deaths by 2040.
US Melanoma Incidence May Be Stabilizing for First Time in a Century
Data suggest the overall incidence of melanoma in the United States is stabilizing after nearly a century of continuous increase.
Pandemic Tied to Drop in New Cancer Diagnoses
At the start of the pandemic, there was an immediate 34.3% decline in the estimated mean cancer incidence volume.
Relatlimab-Nivolumab Prolongs PFS in Metastatic Melanoma
Fixed-dose combination treatment with relatlimab plus nivolumab improved progression-free survival when compared with nivolumab alone.
Opdualag Approved for Unresectable, Metastatic Melanoma
Opdualag is a fixed-dose combination of nivolumab and relatlimab.
Does Aspirin Reduce the Risk of Invasive Melanoma in Older Adults?
Results from a randomized trial neither support nor rule out the possibility that aspirin might have a chemopreventive effect on melanoma incidence.
How the Gut Microbiome Impacts Response to Anti-PD-1 Therapy in Melanoma
Prior studies have linked the gut microbiome with outcomes of anti-PD-1 therapy, but findings have been inconsistent.
FDA-Approved Melanoma Treatments
FDA-approved drug therapies for cutaneous melanoma.
- Loading...
Loading...
Loading... 
Loading...